Search Results - "Siriboonpiputtana, Teerapong"

Committed change of real-time quantitative PCR to droplet digital PCR for monitoring BCR :: ABL1 transcripts in tyrosine kinase inhibitor treated CML by Kongruang, Adcharee, Limsuwanachot, Nittaya, Magmuang, Sutada, Areesirisuk, Prapatsorn, Niparuck, Pimjai, Siriboonpiputtana, Teerapong, Rerkamnuaychoke, Budsaba

“…We performed a feasibility study of an FDA-approved commercial ddPCR assay to measure :: in CML patients treated using TKI therapy. Assay performance of…”
Get full text

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome by Niparuck, Pimjai, Police, Pornnapa, Noikongdee, Phichchapha, Siriputtanapong, Kanchana, Limsuwanachot, Nittaya, Rerkamnuaychoke, Budsaba, Chuncharunee, Suporn, Siriboonpiputtana, Teerapong

“…TP53 mutation is found frequently in therapy related acute myeloid leukemia (AML)/ myelodysplastic syndrome (MDS), AML and MDS patients with monosomy or…”
Get full text

Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients by Kiatprungvech, Nattaradee, Sangkum, Premsant, Malinee, Rozita, Sommaluan, Suchada, Korkiatsakul, Veerawat, Worawichawong, Suchin, Rerkamnuaychoke, Budsaba, Kongruang, Adcharee, Aeesoa, Suraida, Lertsithichai, Panuwat, Kijvikai, Kittinut, Kongchareonsombat, Wisoot, Siriboonpiputtana, Teerapong

“…While recent studies have demonstrated several genetic alterations are associated with pathogenesis of RCC, the significance of cyclin-dependent kinase…”
Get full text

A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia by Limsuwanachot, Nittaya, Rerkamnuaychoke, Budsaba, Niparuck, Pimjai, Singdong, Roongrudee, Kongruang, Adcharee, Hirunpatrawong, Piyapha, Siriyakorn, Thanaporn, Yenchitsomanus, Pa-thai, Siriboonpiputtana, Teerapong

“…•The development of a mass array panel for BCR::ABL1 kinase domain mutations in CML.•Mass array for the detection of JAK2 V617F, MPL W515K/L, and CALR…”
Get full text

HMP-S7 Is a Novel Anti-Leukemic Peptide Discovered from Human Milk by Chiangjong, Wararat, Panachan, Jirawan, Vanichapol, Thitinee, Pongsakul, Nutkridta, Pongphitcha, Pongpak, Siriboonpiputtana, Teerapong, Lerksuthirat, Tassanee, Nuntnarumit, Pracha, Supapannachart, Sarayut, Srisomsap, Chantragan, Svasti, Jisnuson, Hongeng, Suradej, Chutipongtanate, Somchai

“…Chemotherapy in childhood leukemia is associated with late morbidity in leukemic survivors, while certain patient subsets are relatively resistant to standard…”
Get full text

Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms by Singdong, Roongrudee, Siriboonpiputtana, Teerapong, Chareonsirisuthigul, Takol, Kongruang, Adcharee, Limsuwanachot, Nittaya, Sirirat, Tanasan, Chuncharunee, Suporn, Rerkamnuaychoke, Budsaba

“…Background: The discovery of somatic acquired mutations of JAK2 (V617F) in Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs) including…”
Get full text

Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases by Limsuwanachot, Nittaya, Siriboonpiputtana, Teerapong, Karntisawiwat, Kanlaya, Chareonsirisuthigul, Takol, Chuncharunee, Suporn, Rerkamnuaychoke, Budsaba

“…Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous disease which requires a risk-stratified approach for appropriate treatment. Specific…”
Get full text

Mutation Screening and Association Study of the Folylpolyglutamate Synthetase (FPGS) Gene with Susceptibility to Childhood Acute Lymphoblastic Leukemia by Piwkham, Duangjai, Siriboonpiputtana, Teerapong, Beuten, Joke, Pakakasama, Samart, Gelfond, Jonathan AL, Paisooksantivatana, Karan, Tomlinson, Gail E, Rerkamnuaychoke, Budsaba

“…Background: Folylpolyglutamate synthetase (FPGS), an important enzyme in the folate metabolic pathway, plays a central role in intracellular accumulation of…”
Get full text

Application of Gene Expression Microarray for the Classification of Ph-Like B-Cell Acute Lymphoblastic Leukemia by Thangrua, Nonthaya, Siriboonpiputtana, Teerapong, Rerkamnuaychoke, Budsaba, Chareonsirisuthigul, Takol, Korkiatsakul, Veerawat, Pongphitcha, Pongpak, Mukda, Ekchol, Chutipongtanate, Somchai, Pakakasama, Samart

“…Ph-like ALL has gene expression profile similar to Ph-positive ALL but without the BCR::ABL1 fusion. The disease presents higher rates of severe clinical…”
Get full text

Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma by Rujirachaivej, Punchita, Siriboonpiputtana, Teerapong, Luangwattananun, Piriya, Yuti, Pornpimon, Wutti-in, Yupanun, Choomee, Kornkan, Sujjitjoon, Jatuporn, Chareonsirisuthigul, Takol, Rerkamnuaychoke, Budsaba, Junking, Mutita, Yenchitsomanus, Pa-thai

“…Multiple myeloma (MM) is an incurable hematologic malignancy characterized by the rapid proliferation of malignant plasma cells within the bone marrow…”
Get full text

Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand by Limsuwanachot, Nittaya, Kongruang, Adcharee, Rerkamnuaychoke, Budsaba, Singdong, Roongrudee, Niparuck, Pimjai, Jootar, Saengsuree, Siriboonpiputtana, Teerapong

“…The genetic hallmark of CML is known as the appearance of t(9;22)(q34.1;q11.2) (BCR-ABL1) which is present in more than 95% of cases. Here, we demonstrated…”
Get full text

Transcriptional memory of cells of origin overrides β‐catenin requirement of MLL cancer stem cells by Siriboonpiputtana, Teerapong, Zeisig, Bernd B, Zarowiecki, Magdalena, Fung, Tsz Kan, Mallardo, Maria, Tsai, Chiou‐Tsun, Lau, Priscilla Nga Ieng, Hoang, Quoc Chinh, Veiga, Pedro, Barnes, Jo, Lynn, Claire, Wilson, Amanda, Lenhard, Boris, So, Chi Wai Eric

“…While β‐catenin has been demonstrated as an essential molecule and therapeutic target for various cancer stem cells (CSCs) including those driven by MLL…”
Get full text

Determination of the JAK2 V617F mutation in thrombosis patients by Magmuang, Sutada, Singdong, Roongrudee, Chareonsirisuthigul, Takol, Rerkamnuaychoke, Budsaba, Sommaluan, Suchada, Sae-chua, Dollawat, Siriboonpiputtana, Teerapong, Puavilai, Teeraya

“…Background: Janus kinase 2 (JAK2) gene mutation causes uncontrolled myeloproliferation independent of cytokines and abnormal formation of the endogenous…”
Get full text

Targeting UCHL1 Induces Cell Cycle Arrest in High-Risk Multiple Myeloma with t(4;14) by Kamseng, Parin, Siriboonpiputtana, Teerapong, Puavilai, Teeraya, Chuncharunee, Suporn, Paisooksantivatana, Karan, Chareonsirisuthigul, Takol, Junking, Mutita, Chiraphapphaiboon, Wannasiri, Yenchitsomanus, Pa-Thai, Rerkamnuaychoke, Budsaba

“…Multiple myeloma (MM) patients considered to be at high cytogenetic risk commonly fail to respond to standard treatment. A thorough understanding of the…”
Get full text

Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma by Panachan, Jirawan, Rojsirikulchai, Napat, Pongsakul, Nutkridta, Khowawisetsut, Ladawan, Pongphitcha, Pongpak, Siriboonpiputtana, Teerapong, Chareonsirisuthigul, Takol, Phornsarayuth, Pitichai, Klinkulab, Nisakorn, Jinawath, Natini, Chiangjong, Wararat, Anurathapan, Usanarat, Pattanapanyasat, Kovit, Hongeng, Suradej, Chutipongtanate, Somchai

“…amplification is the strongest predictor of high-risk neuroblastoma (NB). The standard procedure to detect status requires invasive procedures. Extracellular…”
Get full text

Extracellular Vesicle-Based Method for Detecting IMYCN/I Amplification Status of Pediatric Neuroblastoma by Panachan, Jirawan, Rojsirikulchai, Napat, Pongsakul, Nutkridta, Khowawisetsut, Ladawan, Pongphitcha, Pongpak, Siriboonpiputtana, Teerapong, Chareonsirisuthigul, Takol, Phornsarayuth, Pitichai, Klinkulab, Nisakorn, Jinawath, Natini, Chiangjong, Wararat, Anurathapan, Usanarat, Pattanapanyasat, Kovit, Hongeng, Suradej, Chutipongtanate, Somchai

“…MYCN gene amplification, the strongest prognostic marker of aggressive neuroblastoma, is detected on invasive biopsy tissues. This study aimed to establish a…”
Get full text

The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome by Rujirachaivej, Punchita, Siriboonpiputtana, Teerapong, Rerkamnuaychoke, Budsaba, Magmuang, Suthada, Chareonsirisuthigul, Takol, Boonsakan, Paisarn, Petvises, Sawang, Sirirat, Tanasan, Niparuck, Pimjai, Chuncharunee, Suporn

“…Genetic mutations in genes encoding critical component of RNA splicing machinery including SF3B1 are frequently identified and recognized as the pathogenesis…”
Get full text

Transcriptional memory of cells of origin overrides [beta]-catenin requirement of MLL cancer stem cells by Siriboonpiputtana, Teerapong, Zeisig, Bernd B, Zarowiecki, Magdalena, Fung, Tsz Kan, Mallardo, Maria, Tsai, Chiou-Tsun, Lau, Priscilla Nga Ieng, Hoang, Quoc Chinh, Veiga, Pedro, Barnes, Jo, Lynn, Claire, Wilson, Amanda, Lenhard, Boris, So, Chi Wai Eric

“…While [beta]-catenin has been demonstrated as an essential molecule and therapeutic target for various cancer stem cells (CSCs) including those driven by MLL…”
Get full text

Mutation Analysis of Isocitrate Dehydrogenase (IDH1/2) and DNA Methyltransferase 3A (DNMT3A) in Thai Patients with Newly Diagnosed Acute Myeloid Leukemia by Sirirat, Tanasan, Chuncharunee, Suporn, Nipaluk, Pimjai, Siriboonpiputtana, Teerapong, Chareonsirisuthigul, Takol, Limsuwannachot, Nittaya, Rerkamnuaychoke, Budsaba

“…Acute myeloid leukemia (AML) is a clonal hematopoietic stem/progenitor cell disorder which features several genetic mutations. Recurrent genetic alterations…”
Get full text

The Utilization of Karyotyping, iFISH, and MLPA for the Detection of Recurrence Genetic Aberrations in Multiple Myeloma by Sommaluan, Suchada, Rerkamnuaychoke, Budsaba, Pauwilai, Teeraya, Chancharunee, Suporn, Onsod, Preeyaporn, Pornsarayuth, Pitichai, Chareonsirisuthigul, Takol, Tammachote, Rachaneekorn, Siriboonpiputtana, Teerapong

“…Multiple myeloma (MM) is a hematological malignancy characterized by abnormal accumulation of clonal plasma cells in the bone marrow. Recently, multiplex…”
Get full text